• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

iScience . Capsid virus-like particle display improves recombinant influenza neuraminidase antigen stability and immunogenicity in mice

tetano

Editor, Senior Moderator
iScience


. 2024 May 20;27(6):110038.
doi: 10.1016/j.isci.2024.110038. eCollection 2024 Jun 21. Capsid virus-like particle display improves recombinant influenza neuraminidase antigen stability and immunogenicity in mice

Hyeog Kang[SUP] 1 [/SUP], Mira Rakic Martinez[SUP] 1 [/SUP], Kara-Lee Aves[SUP] 2 [/SUP], Anna Kathrine Okholm[SUP] 2 [/SUP], Hongquan Wan[SUP] 1 [/SUP], Sylvie Chabot[SUP] 1 [/SUP], Tahir Malik[SUP] 1 [/SUP], Adam F Sander[SUP] 2 3 [/SUP], Robert Daniels[SUP] 1 [/SUP]



Affiliations
Abstract

Supplementing influenza vaccines with additional protective antigens such as neuraminidase (NA) is a promising strategy for increasing the breadth of the immune response. Here, we improved the immunogenicity and stability of secreted recombinant NA (rNA) tetramers by covalently conjugating them onto the surface of AP205 capsid virus-like particles (cVLPs) using a Tag/Catcher ligation system. cVLP display increased the induction of IgG2a subclass anti-NA antibodies, which exhibited cross-reactivity with an antigenically distant homologous NA. It also reduced the single dose rNA amounts needed for protection against viral challenge in mice, demonstrating a dose-sparing effect. Moreover, effective cVLP-display was achieved across different NA subtypes, even when the conjugation was performed shortly before administration. Notably, the rNA-cVLP immunogenicity was retained upon mixing or co-administering with commercial vaccines. These results highlight the potential of this approach for bolstering the protective immune responses elicited by influenza vaccines.

Keywords: Biological sciences; Immune response; Immunology; Natural sciences.

 
Back
Top Bottom